Nurix Therapeutics
NRIX
NRIX
175 hedge funds and large institutions have $1.53B invested in Nurix Therapeutics in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 66 increasing their positions, 47 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
9.1% more ownership
Funds ownership: 105.39% → 114.49% (+9.1%)
2% more funds holding
Funds holding: 172 → 175 (+3)
0% more capital invested
Capital invested by funds: $1.53B → $1.53B (+$2.6M)
Holders
175
Holding in Top 10
4
Calls
$7.17M
Puts
$823K
Top Buyers
| 1 | +$189M | |
| 2 | +$25.4M | |
| 3 | +$25.1M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$19.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$16.4M |
Top Sellers
| 1 | -$16.4M | |
| 2 | -$12.9M | |
| 3 | -$12.8M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$8.05M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$6.81M |